Home / Bioprinting


CELLINK Opens New Japan Office at Kyoto University

The new office at Kyoto University’s Innovation Hub Kyoto will serve as a base for research, as well as facilitating relationships with collaborators in Asia. Due to the high demand of CELLINK technology and its rapid partnership growth within Asia, CELLINK has decided to further establish themselves in the Asian …

Read More »

Poietis Launches Poieskin, the First Commercial Tissue Model Manufactured by Bioprinting

Poietis, a leading bioprinting company, is commercially launching Poieskin, its first bioprinted skin model. The announcement was made by Dr. Fabien Guillemot, President and Scientific Director of Poietis, at the Additive Manufacturing Strategies Conference in Washington, DC; USA, where he participated with a panel of experts at a round table discussion on …

Read More »

Aprecia Pharmaceuticals and Cycle Pharmaceuticals Partner to Develop 3D Printed Orphan Drugs

Aprecia Pharmaceuticals,  a company specializing in the 3D printing of pharmaceuticals, and Cycle Pharmaceuticals, signed a partnership agreement to develop and commercialize orphan drugs using three-dimensionally printed (“3DP”) technology. An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred …

Read More »

Nanoscribe Nano 3D Printer Used for Cell Regeneration and Nerve Interfacing Microdevices

In segments such as regenerative medicine, neuroscience and drug discovery, 3D printing finds practical uses from cartilage repair, hearing aids to printable pills. In the challenge of fabricating biocompatible 3D microdevices, Nanoscribe’s 3D microprinting represents a versatile approach with the interplay of a high-resolution 3D printer and proprietary photo resin …

Read More »

regenHU and Wako Automation Collaborate to Promote 3D Bioprinting in Drug-discovery in the USA

Leading bioprinter manufacturer regenHU appointed Wako Automation as their official systems integrator for the USA. Recent advances in 3D-Bioprinting provide a valuable tool in the fabrication of biomimetic tissue constructs which can be applied at various stages of drug discovery research and development.   “The collaboration with regenHU will enable …

Read More »